BLOG

Saturday, December 1, 2018

Sebi may reopen Sun Pharma insider trading case, probe promoters' lapses

According to sources, alleged irregularities by the company's promoters and others in raising funds through FCCBs are also likely to be investigated by the watchdog

from Companies https://ift.tt/2SjYkB2
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...